Skip to content

688185.SH

CanSino Biologics, Inc.

SSE · Healthcare · Biotechnology · CN

CNY 75.50
−2.35%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.2B1.1B846.3M357.1M1.0B
Cost of Revenue324.3M240.2M204.5M259.4M416.4M
Gross Profit909.6M827.7M641.8M97.7M618.2M
Operating Expenses
R&D Expense300.4M313.0M416.1M638.0M778.3M
SG&A Expense159.2M
General & Admin Expense121.8M158.4M178.7M286.5M268.9M
Selling & Marketing Expense341.5M416.7M369.1M353.4M266.6M
Other Expenses8.7M
Total Operating Expenses958.9M925.4M951.9M1.2B1.1B
Cost and Expenses1.3B1.2B1.2B1.5B1.6B
Operating Income (EBIT)20.4M23.9M(375.2M)(1.9B)(1.2B)
Non-Operating
Interest Income12.5M
Interest Expense5.9M
Net Interest Income6.6M
Other Non-Op Income/Expense28.6M
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)46.9M21.7M(381.2M)(2.0B)(1.2B)
Income Tax Expense6.4M(6.1M)2.5M(11.5M)(219.2M)
Bottom Line
Net Income40.5M27.9M(378.9M)(1.5B)(909.4M)
Earnings from Cont. Ops40.5M27.9M(383.7M)(2.0B)(964.8M)
Earnings from Discont. Ops
Bottom Line Net Income40.5M27.9M(378.9M)(1.5B)(909.4M)
Per Share
Basic EPSCN¥0.17CN¥0.11(CN¥1.53)(CN¥6.01)(CN¥3.68)
Diluted EPSCN¥0.17CN¥0.11(CN¥1.53)(CN¥6.01)(CN¥3.68)
Revenue Per ShareCN¥4.99CN¥4.21CN¥3.42CN¥1.45CN¥4.19
Shares
Basic Shares Outstanding247.0M253.4M247.6M246.7M247.1M
Diluted Shares Outstanding247.0M253.4M247.6M246.7M247.1M
Profitability Metrics
EBITDA60.4M195.0M(173.7M)(1.7B)(993.4M)
D&A48.7M171.1M201.6M246.2M187.3M
EBIT11.7M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026